These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11158422)

  • 1. Cryoglobulinaemic vasculitis caused by intravenous immunoglobulin treatment.
    Odum J; D'Costa D; Freeth M; Taylor D; Smith N; MacWhannell A
    Nephrol Dial Transplant; 2001 Feb; 16(2):403-6. PubMed ID: 11158422
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease.
    Iannaccone S; Sferrazza B; Quattrini A; Smirne S; Ferini-Strambi L
    Neurology; 1999 Sep; 53(5):1154-5. PubMed ID: 10496291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous immunoglobulin therapy in neuroimmunological disorders].
    Komoly S
    Ideggyogy Sz; 2014 Jul; 67(7-8):281-2. PubMed ID: 25509371
    [No Abstract]   [Full Text] [Related]  

  • 6. Rituximab-induced accelerated cryoprecipitation in hepatitis C virus-associated mixed cryoglobulinemia has parallels with intravenous immunoglobulin-induced immune complex deposition in mixed cryoglobulinemia: comment on the article by Sène et al.
    Misbah SA
    Arthritis Rheum; 2010 Oct; 62(10):3122; author reply 3122-3. PubMed ID: 20662059
    [No Abstract]   [Full Text] [Related]  

  • 7. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV.
    Makela P; Howe L; Glover S; Ferguson I; Pinto A; Gompels M
    J Infect; 2002 Jan; 44(1):47-9. PubMed ID: 11972420
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversible Splenial Lesion Syndrome After Intravenous Immunoglobulin Treatment for Guillain-Barre Syndrome.
    Uygur Kucukseymen E; Yuksel B; Genc F; Ozaydin Goksu E; Yildiz S; Bicer Gomceli Y
    Clin Neuropharmacol; 2017; 40(5):224-225. PubMed ID: 28816832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome.
    Korinthenberg R
    Eur J Paediatr Neurol; 1998; 2(1):57-9. PubMed ID: 10726847
    [No Abstract]   [Full Text] [Related]  

  • 10. [Essential mixed cryoglobulinemia type II: case report.].
    Mazzota M; Dotto B; Salazar V; Herrero M; Sesín AM; Dionisio de Cabalier ME; Mukdsi J
    Rev Fac Cien Med Univ Nac Cordoba; 2018 Nov; 75(4):292-298. PubMed ID: 30734709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical comments on the use of immunoglobulins].
    Lewandowicz-Uszyńska A; Swierkot J
    Pol Merkur Lekarski; 2011 Jun; 30(180):448-51. PubMed ID: 21751557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin petechiae and ecchymoses (vasculitis) due to anticoagulant therapy.
    Stavorovsky M; Lichtenstein D; Nissim F
    Dermatologica; 1979; 158(6):451-61. PubMed ID: 467764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal vein occlusion following intravenous immunoglobulin treatment.
    Nawasiwatte BM; Somaratne SC; Fernando A; Gunaratne PS
    Ceylon Med J; 2012 Dec; 57(4):170-1. PubMed ID: 23292061
    [No Abstract]   [Full Text] [Related]  

  • 14. Anaphylaxis with intravenous immunoglobulin: a time for introspection.
    Jain RS; Agrawal R; Kumar S; Gupta PK
    Am J Emerg Med; 2015 Sep; 33(9):1332.e1-2. PubMed ID: 25819200
    [No Abstract]   [Full Text] [Related]  

  • 15. A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome.
    Diener HC; Haupt WF; Kloss TM; Rosenow F; Philipp T; Koeppen S; Vietorisz A;
    Eur Neurol; 2001; 46(2):107-9. PubMed ID: 11528165
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple complications of IVIG therapy in a patient with Guillain-Barré syndrome.
    Steinberger B; Coleman TA
    Am J Hematol; 2001 May; 67(1):59. PubMed ID: 11279662
    [No Abstract]   [Full Text] [Related]  

  • 17. Landry Guillian-Barre Strohl syndrome in pregnancy: use of high-dose intravenous immunoglobulin.
    Seoud M; Naboulsi M; Khalil A; Sarouphim P; Azar G; Khalifeh R
    Acta Obstet Gynecol Scand; 1999 Nov; 78(10):912-3. PubMed ID: 10577623
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recurrent acute polyneuropathy and cutaneous vasculitis].
    Garrigues G; Charif M; Milhaud D; Blard JM; Pagès M
    Rev Neurol (Paris); 2002 Nov; 158(11):1107-9. PubMed ID: 12451344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barré Syndrome Related to Nivolumab: Case Report of a Patient With Urothelial Cancer and Review of the Literature.
    Kyriazoglou A; Liontos M; Papadopoulos C; Bilali A; Kostouros E; Pagoni S; Doumas K; Dimopoulos MA; Bamias A
    Clin Genitourin Cancer; 2019 Apr; 17(2):e360-e364. PubMed ID: 30612920
    [No Abstract]   [Full Text] [Related]  

  • 20. Tamoxifen and purpuric vasculitis: a case report.
    Betto P; Gennari E; Germi L; Bonoldi E; Scalco G; Tosti A
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):762-3. PubMed ID: 18031499
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.